drug

eravacycline dihydrochloride

Marketedupdated 2mo ago

by La Jolla Pharmaceutical Company

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Patent cliff

source: FDA Orange Book

first barrier falls

Aug 27, 2028

~2.1 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (8)

Oct 19, 2037compositionUS 10961190
Oct 19, 2037compositionUS 10961190
Oct 19, 2037compositionUS 11578044
Oct 19, 2037compositionUS 11578044
Dec 28, 2030formulationUS 89068874.5y
Dec 28, 2030formulationUS 89068874.5y
Aug 7, 2029method-of-use (U-2380)US 87962453.1y
Aug 7, 2029method-of-use (U-2380)US 87962453.1y

FDA exclusivities (4)

Aug 27, 2028GAINGAIN Antibiotic (5y)2.1y
Aug 27, 2028GAINGAIN Antibiotic (5y)2.1y
Aug 27, 2023NCENew Chemical Entity (5y)
Aug 27, 2023NCENew Chemical Entity (5y)

Data sources

ClinicalTrials.gov

last refreshed 24m ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?